Dawn Cardeiro

Dawn Cardeiro, MS, is a seasoned professional in the healthcare and diagnostics sectors, currently serving as Market Access Strategy Director at Roche Diagnostics since June 2024. Prior roles include Director of Precision Medicine at Point32Health and Director, Payer Market Access at Foundation Medicine. Dawn's experience also encompasses significant positions at Veracyte, Inc., Courtagen Life Sciences, and Myriad Genetics, where responsibilities ranged from medical affairs to payer relations. Dawn began a career in healthcare at March of Dimes, holding director-level roles, and has a background in genetic counseling and academic instruction at Sarah Lawrence College. An alumnus of Sarah Lawrence College with a Master's in Human/Medical Genetics and Fairfield University with a Bachelor's in Chemistry, Dawn combines extensive clinical and strategic expertise in the field.